HK1180951A1 - 用於遏制光暴露導致的異常皮膚細胞的形成的試劑 - Google Patents

用於遏制光暴露導致的異常皮膚細胞的形成的試劑

Info

Publication number
HK1180951A1
HK1180951A1 HK13108231.7A HK13108231A HK1180951A1 HK 1180951 A1 HK1180951 A1 HK 1180951A1 HK 13108231 A HK13108231 A HK 13108231A HK 1180951 A1 HK1180951 A1 HK 1180951A1
Authority
HK
Hong Kong
Prior art keywords
suppressing
exposure
formation
agent
light
Prior art date
Application number
HK13108231.7A
Other languages
English (en)
Inventor
Mitsuaki Kawamura
Shigeo Shinohara
Fumiki Harano
Akihiro Aoki
Eri Ueno
Original Assignee
大塚製藥株式會社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 大塚製藥株式會社 filed Critical 大塚製藥株式會社
Publication of HK1180951A1 publication Critical patent/HK1180951A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
HK13108231.7A 2010-06-25 2013-07-12 用於遏制光暴露導致的異常皮膚細胞的形成的試劑 HK1180951A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2010145319 2010-06-25
PCT/JP2011/065125 WO2011162416A1 (en) 2010-06-25 2011-06-24 Agent for suppressing the formation of abnormal skin cells caused by exposure to light

Publications (1)

Publication Number Publication Date
HK1180951A1 true HK1180951A1 (zh) 2013-11-01

Family

ID=44534559

Family Applications (1)

Application Number Title Priority Date Filing Date
HK13108231.7A HK1180951A1 (zh) 2010-06-25 2013-07-12 用於遏制光暴露導致的異常皮膚細胞的形成的試劑

Country Status (9)

Country Link
US (1) US9125928B2 (zh)
EP (1) EP2585077B1 (zh)
JP (1) JP5893013B2 (zh)
KR (1) KR20130120450A (zh)
CN (1) CN102985093A (zh)
AU (1) AU2011270096B2 (zh)
ES (1) ES2508591T3 (zh)
HK (1) HK1180951A1 (zh)
WO (1) WO2011162416A1 (zh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10188617B2 (en) 2013-03-12 2019-01-29 The Board Of Trustees Of The Leland Stanford Junior University Modulation of cellular DNA repair activity to intercept malignancy
WO2016090252A1 (en) 2014-12-04 2016-06-09 Mary Kay Inc. Topical skin care composition comprising trifluoroacetyl tripeptide-2
KR101555956B1 (ko) 2015-01-06 2015-10-01 김종일 전기 콘센트
WO2016148324A1 (ko) * 2015-03-19 2016-09-22 (주)아모레퍼시픽 태양광 차단 기능성 물질 스크리닝 방법 및 태양광 차단 효능 평가 방법

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3978213A (en) * 1972-07-10 1976-08-31 Nelson Research & Development Company Cosmetic use of cyclic amp and phosphodiesterase inhibitors
FR2557452B1 (fr) * 1983-12-28 1986-08-14 Roussel Uclaf Nouvelles compositions pour les soins de la peau renfermant de l'huile d'onagre et des traits tissulaires de rate
FR2634374B1 (fr) * 1988-07-19 1993-10-15 Laboratoires Serobiologiques Agents photoprotecteurs, cytophotoprotecteurs cutanes ayant une activite photoprotectrice des cellules constitutives, fonctionnelles de la peau, en particulier des cellules de langerhans, a base de composes nucleiques : nucleoprotides, ribonucleotides et desoxyribonucleotides, ribonucleosides et desoxyribonucleosides, compositions cosmetiques ou dermo-pharmaceutiques contenant un tel agent ainsi que des nouveaux composes en soi
JP3578858B2 (ja) * 1995-12-11 2004-10-20 株式会社ノエビア 皮膚外用剤
US20020006913A1 (en) * 1997-11-04 2002-01-17 Von Borstel Reid W. Antimutagenic compositions for treatment and prevention of photodamage to skin
JP2000119155A (ja) * 1998-10-14 2000-04-25 Kose Corp 皮膚外用剤
WO2001043704A1 (en) 1999-12-14 2001-06-21 Avon Products, Inc. A skin care composition that mediates cell to cell communication
JP2002370986A (ja) * 2001-04-13 2002-12-24 Otsuka Pharmaceut Co Ltd 糖取込促進剤
US7037370B2 (en) * 2003-02-06 2006-05-02 Mearini Gerald T Free-standing diamond structures and methods
TW200514575A (en) 2003-10-08 2005-05-01 Otsuka Pharma Co Ltd Promoting composition for collagen producing
JP5093998B2 (ja) 2004-09-22 2012-12-12 大塚製薬株式会社 色素沈着予防又は改善剤
JP2006096730A (ja) * 2004-09-30 2006-04-13 Naris Cosmetics Co Ltd シワ改善剤
JP2006225271A (ja) 2005-02-15 2006-08-31 Otsuka Pharmaceut Co Ltd シワの予防又は改善剤
JP2007161693A (ja) * 2005-12-12 2007-06-28 Toshiro Azegami 閉経後のホルモンバランス調整及びパーキンソン症の予防改善目的の経口組成物
JP2007238588A (ja) * 2006-03-06 2007-09-20 Toshiro Azegami 美肌効果と下肢静脈瘤及び皮膚ガンの予防改善目的の混合クリームを提供する
JP2009227632A (ja) 2008-03-25 2009-10-08 Ezaki Glico Co Ltd 酵素合成グリコーゲンを含有する皮膚外用剤。

Also Published As

Publication number Publication date
KR20130120450A (ko) 2013-11-04
EP2585077A1 (en) 2013-05-01
WO2011162416A1 (en) 2011-12-29
JP5893013B2 (ja) 2016-03-23
CN102985093A (zh) 2013-03-20
US20130090301A1 (en) 2013-04-11
US9125928B2 (en) 2015-09-08
AU2011270096B2 (en) 2014-06-12
AU2011270096A1 (en) 2012-12-20
JP2013529628A (ja) 2013-07-22
ES2508591T3 (es) 2014-10-16
EP2585077B1 (en) 2014-09-03

Similar Documents

Publication Publication Date Title
HRP20181434T1 (hr) Spojevi za zaštitu stanica
EP2771455A4 (en) CELL LINE FOR GENERATING AN ADENO-ASSOCIATED VIRUS
ZA201308086B (en) Derivatives of 1-anino-2-cyclopropylboronic acid
IL245535A0 (en) A method for introducing cells from solid tissues
HK1178465A1 (zh) 用於改善皮膚狀態的組合物
EP2654745A4 (en) COMPOSITION FOR TREATING SKIN CONDITIONS OF THE SKIN
PL2867218T3 (pl) Pochodne kwasu dimetylobenzoesowego użyteczne w leczeniu stanów zapalnych
EP2661179A4 (en) COMPOSITION WITH REDUCED SODIUM CONTENT
EP2601178A4 (en) SALTS OF LAPATINIB
IL224381B (en) Application of b-functionalized dihydroxy-chlorins for pdt
HK1180951A1 (zh) 用於遏制光暴露導致的異常皮膚細胞的形成的試劑
EP2768481A4 (en) COMPOSITIONS TO REDUCE SIDE EFFECTS
EP2708230A4 (en) COMPOSITION FOR APPEARANCE ON THE SKIN FOR INFLAMMATORY DISEASES
GB201104001D0 (en) Improvements to goggles
IL227930A0 (en) cell division enhancer
EP2782902A4 (en) DERIVATIVES FROM PHENOXYISOBUTTERIC ACID
EP2791349A4 (en) SYNTHESIS OF N-ACETYL-D-NEURAMIC ACID
PL2677934T3 (pl) Sposoby monitorowania ekspozycji na zdarzenie
EP2785380A4 (en) TREATMENT OF B-CELL LYMPHOMES
TWM390794U (en) Improved structure of mask
TWM402477U (en) Structure of laser wind-activating flashing pieces
GB201010671D0 (en) Compounds for treatment of inflammation
GB201005495D0 (en) Compounds for treatment of inflammation
GB201220786D0 (en) Improvements relating to the management of strategy
AU2011903969A0 (en) Compositions for treating skin conditions

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20190620